NAV-KIDS2 trial: protocol for a multi-centre, staggered randomised controlled trial of a patient navigator intervention in children with chronic kidney disease
Anita van Zwieten(The University of Sydney), Germaine Wong(Children's Hospital at Westmead), Fiona Mackie, Siah Kim, Allison Tong(The University of Sydney), Jonathan C. Craig(Flinders University), Chandana Guha(The University of Sydney), Seán Kennedy(Environmental Protection Agency), Armando Teixeira‐Pinto(The University of Sydney), Hugh J. McCarthy(University of Bristol), Shilpanjali Jesudason(South Australia Pathology), Reginald Woodleigh(Prostate Cancer Foundation of Australia), Patrina Caldwell(Children's Hospital at Westmead), Kirsten Howard(The University of Sydney), Stephen I. Alexander(University of South Australia), Martin Howell(UNSW Sydney), Carmel M. Hawley(The University of Queensland), Amanda Walker(Royal Children's Hospital), Simon Carter(Royal Children's Hospital), Steve McTaggart(Children's Health Queensland Hospital and Health Service), Sam Crafter(Women's and Children's Hospital)
Cited by 17
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|708
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
|The Lancet|2015|394
Overview of a workshop on screening methods for detecting potential (anti-) estrogenic/androgenic chemicals in wildlife
|Environmental Toxicology and Chemistry|1998|288